Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 8Active not recruiting 6Completed 4Unknown 3Terminated 3Withdrawn 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 3

Conditions

Neoplasms 4Prostatic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Testicular Neoplasms 1Skin Diseases 1Retinoblastoma 1Post-Acute COVID-19 Syndrome 1Pathological Conditions, Anatomical 1Neuroblastoma 1Neoplasms, Plasma Cell 1Mouth Neoplasms 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Promyelocytic, Acute 1Infertility, Male 1Hematologic Diseases 1Heart Failure 1Fallopian Tube Neoplasms 1Communicable Diseases 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Basal Cell 1Bronchial Neoplasms 1Brenner Tumor 1Basal Cell Nevus Syndrome 1

Interventions

Docetaxel 21Radiosurgery 19Radiotherapy 17Androgen Antagonists 14Leuprolide 11Goserelin 11bicalutamide 9enzalutamide 8Surveys and Questionnaires 8Prednisone 8Brachytherapy 8Blood Specimen Collection 8Abiraterone Acetate 8acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 7Radiotherapy, Intensity-Modulated 7Multiparametric Magnetic Resonance Imaging 7Gonadotropin-Releasing Hormone 7Triptorelin Pamoate 6pembrolizumab 4cabazitaxel 4abiraterone 4Standard of Care 4Positron Emission Tomography Computed Tomography 4Metformin 4Heavy Ion Radiotherapy 4Exercise 4Estramustine 4luprolide acetate gel depot 3darolutamide 3Watchful Waiting 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Prostatic Neoplasms × Watchful Waiting × Clear all
NCT04102904 2020-03-26

PLiS

University College, London

Unknown
300 enrolled
Genitourinary

Prostatic Neoplasms

NCT00376792 2013-08-26

Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
396 enrolled
Genitourinary

Prostatic Neoplasms

NCT01193855 2013-08-26

Dutasteride in Treating Patients With Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
42 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡